Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 41 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

20%

8 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (20)
P 2 (3)
P 3 (6)
P 4 (2)

Trial Status

Recruiting15
Not Yet Recruiting14
Completed7
Active Not Recruiting3
Enrolling By Invitation2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 7 completed trials

Clinical Trials (41)

Showing 20 of 20 trials
NCT07167004Not ApplicableRecruiting

The GRoceries Aimed at Increasing Nutrition Study

NCT07743983Phase 3RecruitingPrimary

A Study of BGM0504 in Early T2DM With Obesity

NCT07743021Recruiting

Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data

NCT07156370Recruiting

Salivary Cortisol and Hypercortisolism in Type 2 Diabetes

NCT07097415Not ApplicableCompletedPrimary

CGM-Assisted Community Management for Type 2 Diabetes

NCT07706010Not Yet RecruitingPrimary

Cardiovascular Risk in T2DM With MAFLD: A Cohort Study

NCT07690163Not ApplicableRecruitingPrimary

DIabetes GLycemic Assessment in Newly Confirmed Episodes

NCT07702097Not ApplicableNot Yet Recruiting

Effect of Ajwa Seed Powder on HbA1c and Body Composition in Overweight and Obese Patients With Type 2 Diabetes Mellitus

NCT07139405Phase 2Not Yet RecruitingPrimary

TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy

NCT07675187Not ApplicableNot Yet RecruitingPrimary

HCC Risk and Monitoring in Patients With Type 2 Diabetes

NCT07527078Phase 3RecruitingPrimary

Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes

NCT07416656Recruiting

Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine

NCT07665567Enrolling By InvitationPrimary

Remission Evaluation of Metabolic Interventions in Type 2 Diabetes in Primary Care (REMIT-Prime)

NCT07636161Phase 4Not Yet Recruiting

PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

NCT07627048CompletedPrimary

Influence of Gut Microbiota on the Development of Type 2 Diabetes Mellitus and Personalization of Diabetes-lowing Therapy

NCT07609992Not ApplicableCompletedPrimary

The Effect of OptiFibre Dietary Fiber on Carbohydrate Metabolism and Intestinal Microbiota Metabolism in Patients With Type 2 Diabetes Mellitus

NCT07317115Not ApplicableRecruiting

Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

NCT07155902Not ApplicableNot Yet RecruitingPrimary

Implementing WHO HEARTS-D Guidelines in Bangladesh for Diabetes Control and Prevention

NCT07566845Not ApplicableEnrolling By Invitation

Women With Previous GDM and the Effects of HIIT.

NCT07043816Not ApplicableNot Yet RecruitingPrimary

Impact of PharmaTE Trial on Glycemic Control, Diabetes Knowledge, Medication Adherence and Quality of Life in Type 2 Diabetes Patients: A Mixed-Method Study Protocol

Scroll to load more

Research Network

Activity Timeline